FMED Fidelity Disruptive Medicine ETF

Share ▾
Share on XDownload as PDF
$33.23
+2.2% · 1 day, price
IQ’s readingComputed nightly from ETFIQ data. Not written live.

Over the year to Oct 28, 2026, FMED returned 25.1%.

Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companiesFidelity ↗Expense ratio 0.50%Fund assets $52m on Sep 30, 2026First traded Jun 12, 2023Benchmark Its own holdings, as of May 31, 2026; its prospectus names no index it tracksSEC filings ↗Every Fidelity fund ETFIQ coversDividend history

Promise check: Not measuredIts theme exposure is measured once ETFIQ defines its theme company by company.

FMED risk and return scorecard

vs its own holdings

Not measured: its benchmark is its own holdings, which has no weekly price series.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records; risk-free rate: U.S. Treasury, Daily Treasury Bill Rates, 13-week coupon equivalent Method · Data

Money in and out

Net fund flows · May 31, 2026
12 months to May 31, 2026
−$12.2m
3 years to May 31, 2026
+$35.6m
Since Jun 2023
+$35.6m

What you earned

FMED +2.4%: total return over one month to Oct 28, 2026.
FMED+2.4%
FMED +16.8%: total return over three months to Oct 28, 2026.
FMED+16.8%
FMED +37.1%: total return over six months to Oct 28, 2026.
FMED+37.1%
FMED +22.9%: total return over the year to Oct 28, 2026.
FMED+22.9%
FMED +25.1%: total return over one year to Oct 28, 2026.
FMED+25.1%
FMED +66.9%: total return over three years to Oct 28, 2026.
FMED+66.9%
FMED +32.1%: total return since launch to Oct 28, 2026.
FMED+32.1%

What did you actually buy?

Broad innovation and megatrends · holdings as of Aug 31, 2026
25.3%
Already in the S&P 500
97.1%
Active share vs the S&P 500
31.4%
Top ten holdings
+25.1%
Total return, 1 year
$0.112
Last payment, ex-date Dec 20, 2024
Share already in the S&P 500
25.3% of the fund by weight, holdings as of Aug 31, 2026.
Ten largest holdings
UCB SA4.7%
LIFESTANCE HEALTH GROUP INC4.3%
DANAHER CORP3.4%
10X GENOMICS INC3.1%
INTUITIVE SURGICAL INC2.9%
COGENT BIOSCIENCES INC2.9%
ALNYLAM PHARMACEUTICALS INC2.8%
ARGENX SE2.8%
LEGEND BIOTECH CORP2.3%
UNITEDHEALTH GROUP INC2.3%

More on FMED

Every number below is on this page. Open what you need.

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price, 1 year

$33.23+2.2%1 day, priceClose, Oct 28, 2026

Price only. No distribution was paid over these days, so total return is the same. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Oct 28, 2026. Updated every trading night. Report a data error

FMED returns by window: total return, cash paid and price change
WindowTotal returnS&P 500 (SPY)
1M Sep 28 – Oct 28, 2026+2.4%+0.9%
3M Jul 29 – Oct 28, 2026+16.8%+6.1%
6M Apr 29 – Oct 28, 2026+37.1%+9.1%
YTD Dec 31, 2025 – Oct 28, 2026+22.9%+14.1%
1Y Oct 28, 2025 – Oct 28, 2026+25.1%+13.6%
3Y Oct 27, 2023 – Oct 28, 2026+66.9%+95.0%
Since launch Jun 12, 2023 – Oct 28, 2026+32.1%+85.9%
Since launch, annualised Jun 12, 2023 – Oct 28, 2026+8.6%–

Total returns, distributions reinvested.

Source: Tiingo end-of-day prices, with distributions reinvested.

Money in and out

Monthly data · as of May 31, 2026

FMED: in the month to May 31, 2026, net $17.4m went out, by its SEC filing.

12 months
−$12.2m
−24.7% of $49.6m on May 31, 2025
Jun 1, 2025 to May 31, 2026
monthly, from SEC filings
3 years
+$35.6m
Jun 1, 2023 to May 31, 2026
monthly, from SEC filings
Since Jun 2023
+$35.6m
Jun 1, 2023 to May 31, 2026
monthly, from SEC filings

Computed by ETFIQ from the monthly sales and redemptions FMED files with the SEC on Form N-PORT.

How this is computed

ETFIQ reads no daily data for this fund, so its flows are monthly, and the latest month filed is May 2026. Every day and month ETFIQ holds for FMED, back to Jun 2023, is in its flows file. Flows across every fund · How these flows are computed · Compare FMED with other funds in the flows tool

Month by month, money in and money outJun 2023 to May 2026

FMED, money in and money out each month from Jun 2023 to May 2026: two bars a month, money in above the line and money out below. Every bar is from FMED’s SEC filings (N-PORT item B.6). Of the 36 months listed, money came in on net in 5 and went out in 1.

Every bar is from FMED’s SEC filings (N-PORT item B.6). Of the 36 months listed, money came in on net in 5 and went out in 1.

MonthInOutNet
May 2026 SEC Form N-PORT$0−$17.4m−$17.4m
Apr 2026 SEC Form N-PORT$0$0$0
Mar 2026 SEC Form N-PORT$0$0$0
Feb 2026 SEC Form N-PORT$0$0$0
Jan 2026 SEC Form N-PORT$0$0$0
Dec 2025 SEC Form N-PORT+$2.8m$0+$2.8m
Nov 2025 SEC Form N-PORT$0$0$0
Oct 2025 SEC Form N-PORT$0$0$0
Sep 2025 SEC Form N-PORT$0$0$0
Aug 2025 SEC Form N-PORT$0$0$0
Jul 2025 SEC Form N-PORT$0$0$0
Jun 2025 SEC Form N-PORT+$2.4m$0+$2.4m
May 2025 SEC Form N-PORT$0$0$0
Apr 2025 SEC Form N-PORT$0$0$0
Mar 2025 SEC Form N-PORT$0$0$0
Feb 2025 SEC Form N-PORT$0$0$0
Jan 2025 SEC Form N-PORT$0$0$0
Dec 2024 SEC Form N-PORT$0$0$0
Nov 2024 SEC Form N-PORT$0$0$0
Oct 2024 SEC Form N-PORT$0$0$0
Sep 2024 SEC Form N-PORT$0$0$0
Aug 2024 SEC Form N-PORT$0$0$0
Jul 2024 SEC Form N-PORT$0$0$0
Jun 2024 SEC Form N-PORT$0$0$0
May 2024 SEC Form N-PORT$0$0$0
Apr 2024 SEC Form N-PORT$0$0$0
Mar 2024 SEC Form N-PORT$0$0$0
Feb 2024 SEC Form N-PORT$0$0$0
Jan 2024 SEC Form N-PORT$0$0$0
Dec 2023 SEC Form N-PORT$0$0$0
Nov 2023 SEC Form N-PORT$0$0$0
Oct 2023 SEC Form N-PORT$0$0$0
Sep 2023 SEC Form N-PORT+$9.1m$0+$9.1m
Aug 2023 SEC Form N-PORT$0$0$0
Jul 2023 SEC Form N-PORT+$2.5m−$2.5m+$20k
Jun 2023 SEC Form N-PORT+$39.2m−$442k+$38.8m

Most recent first.

How this is computed

N-PORT months: money in is sales plus reinvestments; money out is redemptions.

N-PORT months are the filed sales plus reinvestments less redemptions. Later months add up the daily data; the Source column names any missing day.

Source: ETFIQ, from the fund’s SEC N-PORT filings. Data as of May 31, 2026. Updated when the fund files its next report.

FMED key stats

52-week high, daily closes to Oct 28, 2026 (ETFIQ)$33.24 on Oct 28, 2026
52-week low, daily closes to Oct 28, 2026 (ETFIQ)$23.55 on Mar 30, 2026
Close on Oct 28, 2026, within that range (ETFIQ)$33.24, 100% of the way from the low to the high
Holdings68
Top ten holdings weight31.4%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Aug 12, 2026
Trading · FMEDas of Aug 12, 2026
·
Not scored1 of 6 measured · Aug 12, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
One dealer
How to tradeSpread not read.
Full trading page: components, premium history, dealers →

FMED top ten by weight, 33.2% of the fund, of its 72 equity positions, from the holdings filed for Aug 31, 2026. Source: the fund’s SEC filing.

DANAHER CORP DHR 3.73%
NATERA INC NTRA 3.30%
ARGENX SE not filed 3.20%
ILLUMINA INC ILMN 2.82%
MODERNA INC MRNA 2.72%
HEARTFLOW INC HTFL 2.59%

Source: Holdings filing (SEC Form N-PORT). Data as of Aug 31, 2026.

About FMED

Theme (ETFIQ, editorial)Broad innovation and megatrends
First tradedJun 12, 2023
History (N-CSRS, Jan 22, 2024; N-CSRS, Jan 22, 2024)Converted from a mutual fund on Jun 9, 2023; the fund started on Apr 16, 2020
Already in the S&P 500, by weight (ETFIQ)25.3%
Outside the S&P 500, by weight (ETFIQ)75%
Active share vs the S&P 500 (ETFIQ)97.1%
Already in the Nasdaq-100, by weight (ETFIQ)8.7%
Active share vs the Nasdaq-100 (ETFIQ)98.9%
Top ten holdings weight31.4%
Holdings68
Holdings as of (SEC N-PORT)Aug 31, 2026
Top holdingsUCB SA 4.7%, LIFESTANCE HEALTH GROUP INC 4.3%, DANAHER CORP 3.4%, 10X GENOMICS INC 3.1%, INTUITIVE SURGICAL INC 2.9%, COGENT BIOSCIENCES INC 2.9%, ALNYLAM PHARMACEUTICALS INC 2.8%, ARGENX SE 2.8%, LEGEND BIOTECH CORP 2.3%, UNITEDHEALTH GROUP INC 2.2%
Net assets (the issuer’s own number for this ETF, month end, as of Sep 30, 2026)$52mReport
Benchmark (ETFIQ, from its filings)Its own holdings, as of May 31, 2026; its prospectus names no index it tracks
Below its all-time high (ETFIQ)0.0%
Expense ratio (485BPOS XBRL, Sep 24, 2026)0.50%Report
Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ)0.51%
Closest funds by holdings overlapHLTH 32%, IBB 28%, IBBQ 26%, GDOC 26%, GNMX 24%
How we measure
Holdings from the fund’s latest public SEC N-PORT filing; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. Method
IQ Investment Committee on FMED

12 seats on FMED, as of Oct 28, 2026: 2 Supports, 5 Challenges, 5 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyNot enough data
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherChallenges
In the tradition ofHoward MarksMarks-style Cycles & RiskChallenges
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationNot enough data
In the tradition ofJesse LivermoreLivermore-style Trend FollowingSupports
Uses ETFIQ’s measuresThe ETFIQ SkepticETFIQ’s own seatSupports
Put FMED to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Questions people ask about FMED

How much of FMED is in S&P 500 companies?
By its holdings filed for Aug 31, 2026, 25% of FMED by weight is stocks the S&P 500 already holds. Its active share against the index is 97%, so that share is the part doing something different.
What does FMED hold?
68 positions as filed for Aug 31, 2026, with the top ten at 31% of the fund. The largest are UCB SA at 4.7%, LIFESTANCE HEALTH GROUP INC at 4.3%, DANAHER CORP at 3.4%.
Has FMED beaten the S&P 500?
Over the year to Oct 28, 2026 FMED returned +25.1% with distributions reinvested, against +13.6% for the S&P 500, so it finished ahead of the index by 11.5 points.
What does FMED cost?
The prospectus expense ratio is 0.50% a year. Because 97% of the fund differs from the S&P 500, the fee on that differing part works out at 0.51%.
Sources and dates
Prices, FMED and S&P 500 (SPY)Tiingo end-of-day · Oct 28, 2026
Net assets, $52mThe issuer’s own number for this ETF, month end · Sep 30, 2026

Links are sources, not endorsements.

Cite this pageCitation, APA and Markdown

ETFIQ, FMED, thematic ETFs, data as of Oct 28, 2026. https://etfiq.com/funds/fmed

The difference bar for FMED, redrawn every trading night.

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

How differently the money is placed, counting weights: one minus the sum of the smaller weight of each security across the fund and the index. 100% means nothing in common; 0% means the index itself. Two funds can hold the same names and still have a high active share if they weight them very differently.
Weight overlap
The share of money two portfolios hold in the same securities at the same weight.
Already in the index
The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at different weights.
The weight of the ten largest holdings. Above 50% the fund is a bet on a handful of companies, whatever the theme.
Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

FMED: 25% of FMED's weight is in S&P 500 companies and 75% is outside the index. Holdings as of May 31, 2026.
<figure style="margin:0;max-width:640px">
<a href="https://etfiq.com/funds/fmed"><img src="https://etfiq.com/assistant/api/embed/themes/fmed.svg" alt="FMED: 25% of FMED&#x27;s weight is in S&amp;P 500 companies and 75% is outside the index. Holdings as of May 31, 2026." width="640" style="max-width:100%;height:auto"></a>
<figcaption style="font:13px/1.5 sans-serif">FMED: 25% of FMED&#x27;s weight is in S&amp;P 500 companies and 75% is outside the index. Holdings as of May 31, 2026. Data: <a href="https://etfiq.com/funds/fmed">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Oct 28, 2026. More on the tabs above.